Multi-BIRW:a network-based algorithm for drug repurposing
Ferraro, L.
Show abstract
This paper is based on Computational Biology with an eye towards medicine. In fact our aim is to identify new indications for existing drugs with a computational approach using Systems Biology, in order to speed up the market entry, avoiding some phases of drug development (for example toxicity tests) and with a lower cost. The method that we will discuss exploits the concept of Random Walk in a heterogeneous network, formed by a drug-drug and disease-disease similarity and known drug-disease associations. This is done by combining different types of data in order to connect more effectively two drugs or two diseases with a similarity score. At the end we integrate the known associations between drugs and diseases with the purpose of finding similarity values of new couples.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Predicting Adverse Drug Effects: A Heterogeneous Graph Convolution Network with a Multi-layer Perceptron Approach 97%
- Improving prediction of drug-target interactions based on fusing multiple features with data balancing and feature selection techniques 96%
- Antivirals for Monkeypox Virus: Proposing an Effective Machine/Deep Learning Framework 96%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.